DEA Diversion Enforcement News - March 2023

U.S. Drug Enforcement Administration sent this bulletin at 03/01/2023 03:45 PM EST

Having trouble viewing this email? View it as a Web page.

DEA Diversion Enforcement News

DEA’s Diversion Control Division strives to prevent, detect, and investigate the diversion of controlled pharmaceuticals and listed chemicals from legitimate sources. When the safety and health of the American people is in jeopardy, DEA takes action against those who violate the law.

Read the latest enforcement cases and civil actions:

February 2, 2023

Nine Arrested for Illegally Distributing 1.5 Million Opioid Pills

February 3, 2023

Missouri Doctor Admits Diluting Clinic’s Methadone

February 9, 2023

Madison Heights Pharmacist Sentenced for Diverting Over 25,000 Opioid Pills

February 15, 2023

Former Office Manager of New Jersey Medical Practice Admits Conspiring with Doctor to Divert Controlled Substances

February 17, 2023

Queens Pharmacist Pleads Guilty to Illegally Distributing Oxycodone and Filing False Tax Returns

February 24, 2023

Physician Agrees to $190,731 Settlement Relating to Controlled Substances Act Claims

Read More

Follow DEA on social media @DEAHQ

You have received this e-mail because you have asked to be notified of changes to the U.S. Department of Justice Web site. Update your subscription to this service, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. If you have questions about the Department of Justice Web site, please contact webmaster@usdoj.gov.

GovDelivery is providing this service on behalf of the Department of Justice and may not use your subscription information for any other purposes.

Department of Justice Privacy Policy
GovDelivery Privacy Policy